About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Prostate Cancer Clinical Trials in Tennessee | 386 Studies

Clinical Trials Prostate CancerTennessee

Prostate Cancer Clinical Trials in Tennessee

Find 386 clinical trials for prostate cancer near Tennessee. Connect with research centers in your area.

All Prostate Cancer trials nationwide All trials in Tennessee

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 21-40 of 386 trials

CompletedA Study of Nivolumab or Placebo in Combination With Docetaxel in Men With Advanced Castration-resistant Prostate CancerThe purpose of this study is to assess the safety and effectiveness of nivolumab with docetaxel in men with advanced castration resistant prostate cancer who have progressed after…NCT04100018·Mobile, Alabama and 292 others

Prostate Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedPhase 2 Trial of Enzastaurin in Prostate Cancer in Participants Who Have Had Hormonal and ChemotherapyThe purpose is to see how quickly two different types of prostate cancer participants respond when taking enzastaurin.NCT00428714·Los Angeles, California and 10 others

TerminatedSunitinib Plus Prednisone In Patients With Metastatic Castration-Resistant Prostate Cancer After Failure Of Docetaxel ChemotherapyThis study will compare the safety and efficacy of sunitinib in combination with prednisone versus placebo and prednisone in patients that have metastatic castration-resistant…NCT00676650·Decatur, Alabama and 204 others

CompletedA Study of HSP90 Inhibitor AT13387 Alone or in Combination With Abiraterone AcetateA 2-part, Phase 1-2, open-label, parallel group, randomized study in patients with Castration-Resistant Prostate Cancer (CRPC) who are no longer responding to treatment with…NCT01685268·Los Angeles, California and 31 others

Active not recruitingTesting Two Oral Drugs Combination (Cediranib and Olaparib) Compared to a Single Drug (Olaparib) for Men With Advanced Prostate CancerThis randomized phase II trial studies how well olaparib with or without cediranib works in treating patients with castration-resistant prostate cancer that has spread to other…NCT02893917·La Jolla, California and 15 others

Active not recruitingSafety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLCThis is a First-in-Human Phase IA/IB/II open label dose escalation study of intravenous (IV) administration of ONC-392, a humanized anti-CTLA4 IgG1 monoclonal antibody, as single…NCT04140526·Springdale, Arkansas and 36 others

CompletedRadiation Therapy With or Without Antiandrogen Therapy in Treating Patients With Stage I or Stage II Prostate CancerRATIONALE: Radiation therapy (RT) uses high-energy x-rays to damage tumor cells. Androgens can stimulate the growth of prostate cancer cells.NCT00002597·Birmingham, Alabama and 238 others

Active not recruitingA Prospective Comparative Study of Outcomes With Proton and Photon Radiation in Prostate CancerThis study is a large, prospective, pragmatic, controlled comparison of patient-centric outcomes \[quality of life (QOL), toxicity, and disease control\] between parallel cohorts…NCT03561220·Birmingham, Alabama and 52 others

CompletedAZD5153 in Patients With Relapsed or Refractory Solid Tumors, Including LymphomasThis is a first-time-in-man (FTIM) multicenter, dose escalation study designed to investigate the safety, pharmacokinetics, and pharmacodynamics of AZD5153 in patients with…NCT03205176·Sarasota, Florida and 3 others

CompletedS0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone MetastasesRATIONALE: Gathering information about how often osteonecrosis of the jaw occurs in patients receiving zoledronic acid for bone metastases may help doctors learn more about the…NCT00874211·Anniston, Alabama and 452 others

Active not recruitingA Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for the Treatment of Participants With Deleterious Germline or Somatic Homologous Recombination Repair (HRR) Gene-MutatedProstatic Neoplasms (mCSPC)The purpose of the study is to determine if the combination of niraparib with Abiraterone Acetate (AA) plus prednisone compared with AA plus prednisone in participants with…NCT04497844·Homewood, Alabama and 386 others

UnknownMulti-Institutional Registry for Prostate Cancer RadiosurgeryTo address pertinent questions regarding the utilization of stereotactic Body Radiotherapy (SBRT) to treat prostate cancer.NCT01226004·Birmingham, Alabama and 43 others

RecruitingMetastatic Castrate-Resistant Prostate Cancer Subjects Treated With PROVENGE® + One Infusion of Sipuleucel-TA multicenter, open-label, prospective study to investigate immune boost response changes in patients with metastatic castrate-resistant prostate cancer (mCRPC).NCT06134232·Tuscon, Arizona and 30 others

CompletedA Study of BIND-014 Given to Patients With Advanced or Metastatic CancerThe goal of this Phase 1 clinical research study is to find the highest safe dose of BIND-014 that can be given in the treatment of patients with advanced or metastatic cancer.NCT01300533·Scottsdale, Arizona and 5 others

CompletedSe-Methyl-Seleno-L-Cysteine or Selenomethionine in Preventing Prostate Cancer in Healthy ParticipantsThis randomized phase I trial studies the side effects and the best dose of Se-methyl-seleno-L-cysteine or selenomethionine in preventing prostate cancer in healthy participants.NCT01497431·Chicago, Illinois and 2 others

RecruitingTrial of Xaluritamig in Adults With Metastatic Castration-resistant Prostate CancerThe primary objective of this trial is to determine the safety profile of xaluritamig at the proposed regimen in adult participants with metastatic castration-resistant prostate…NCT07493512·Denver, Colorado and 13 others

CompletedLeuprolide Acetate 3.75 mg Depot to Treat Prostate CancerThe purpose of this study is to look at the efficacy and safety of leuprolide acetate in patients with prostate cancer.NCT00128531·Homewood, Alabama and 27 others

RecruitingA Phase III Trial of BNT324 Versus Docetaxel in Metastatic Castration-resistant Prostate CancerThis study will test whether BNT324 is safe and works better against metastatic castration-resistant prostate cancer (mCRPC) than the current standard of care (SoC) chemotherapy…NCT07365995·Santa Barbara, California and 51 others

TerminatedSalvage Cryotherapy in Recurrent Prostate CancerTo provide a systemic, uniform and user-friendly tool for collection of data on prostate cancer salvage cryotherapy in a multicenter setting.NCT00824928·Loma Linda, California and 16 others

CompletedA Safety Trial of MVA-BN®-PRO in Men With Androgen-Insensitive Prostate CancerBNIT-PR-001 is an open-label, multi-center, Phase I dosing evaluation trial of MVA-BN®-PRO in men with androgen-insensitive prostate cancer.NCT00629057·Homewood, Alabama and 6 others

PreviousPage 2 of 20Next

Other Conditions in Tennessee

Breast Cancer Lung Cancer Colorectal Cancer Melanoma Leukemia Lymphoma